Sarepta Therapeutics, Inc. (SRPT)
19.73
-0.55
(-2.71%)
USD |
NASDAQ |
Feb 04, 16:00
19.75
+0.02
(+0.10%)
After-Hours: 20:00
Sarepta Therapeutics EPS Diluted (Quarterly) : -1.795 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | -0.2898 |
| Merck & Co., Inc. | 1.191 |
| Arrowhead Pharmaceuticals, Inc. | -0.175 |
| Keros Therapeutics, Inc. | -0.1792 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -179.95M |
| Revenue (Quarterly) | 399.36M |
| Total Expenses (Quarterly) | 579.30M |
| Enterprise Value | 2.467B |
| Gross Profit Margin (Quarterly) | 57.63% |
| Profit Margin (Quarterly) | -45.06% |
| Earnings Yield | -14.66% |
| Normalized Earnings Yield | -7.953 |